Acutaas Chemicals Ltd

Acutaas Chemicals announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Net profit of Acutaas Chemicals rose 110.88% to Rs 131.76 crore in the quarter ended March 2026 as against Rs 62.48 crore during the previous quarter ended March 2025. Sales rose 40.28% to Rs 432.75 crore in the quarter ended March 2026 as against Rs 308.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 124.47% to Rs 356.26 crore in the year ended March 2026 as against Rs 158.71 crore during the previous year ended March 2025. Sales rose 33.02% to Rs 1339.37 crore in the year ended March 2026 as against Rs 1006.88 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales432.75308.48 40 1339.371006.88 33 OPM %42.4127.54 -35.8723.05 - PBDT193.4390.13 115 518.71242.78 114 PBT183.8082.83 122 482.73216.16 123 NP131.7662.48 111 356.26158.71 124 Powered by Capital Market - Live

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 30 April 2026.

Ipca Laboratories Ltd, Blue Star Ltd, Westlife Foodworld Ltd and Hyundai Motor India Ltd are among the other losers in the BSE's 'A' group today, 01 April 2026.Acutaas Chemicals Ltd lost 10.38% to Rs 2292.7 at 14:45 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 63795 shares were traded on the counter so far as against the average daily volumes of 23658 shares in the past one month.Ipca Laboratories Ltd crashed 5.12% to Rs 1521. The stock was the second biggest loser in 'A' group.On the BSE, 25108 shares were traded on the counter so far as against the average daily volumes of 87704 shares in the past one month.Blue Star Ltd tumbled 4.97% to Rs 1530.4. The stock was the third biggest loser in 'A' group.On the BSE, 2.84 lakh shares were traded on the counter so far as against the average daily volumes of 28329 shares in the past one month.Westlife Foodworld Ltd dropped 4.92% to Rs 459.8. The stock was the fourth biggest loser in 'A' group.On the BSE, 24105 shares were traded on the counter so far as against the average daily volumes of 8239 shares in the past one month.Hyundai Motor India Ltd slipped 4.18% to Rs 1703.7. The stock was the fifth biggest loser in 'A' group.On the BSE, 2.71 lakh shares were traded on the counter so far as against the average daily volumes of 1.12 lakh shares in the past one month.

Net profit of Acutaas Chemicals rose 140.18% to Rs 107.96 crore in the quarter ended December 2025 as against Rs 44.95 crore during the previous quarter ended December 2024. Sales rose 42.98% to Rs 393.18 crore in the quarter ended December 2025 as against Rs 274.99 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales393.18274.99 43 OPM %38.3224.97 - PBDT154.4969.65 122 PBT144.6763.33 128 NP107.9644.95 140 Powered by Capital Market - Live

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live

Net profit of Acutaas Chemicals rose 93.52% to Rs 72.24 crore in the quarter ended September 2025 as against Rs 37.33 crore during the previous quarter ended September 2024. Sales rose 24.10% to Rs 306.20 crore in the quarter ended September 2025 as against Rs 246.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales306.20246.73 24 OPM %31.1319.83 - PBDT104.5856.87 84 PBT96.1850.04 92 NP72.2437.33 94 Powered by Capital Market - Live

Profit before tax (PBT) soared 92.19% YoY to Rs 96.17 crore in Q2 FY26. In Q2 FY26, EBITDA jumped 94.8% to Rs 953 crore compared with Rs 489 core in Q2 FY25. EBITDA margin increased 31.1% in Q2 FY26 as against 19.8% in Q2 FY25. Naresh Patel, executive chairman & managing director, Acutaas Chemicals, said: 'Our focus has always been on building a long-term, sustainable business rather than chasing short-term opportunities. This disciplined approach is now yielding tangible results as we strengthen global partnerships and expand into new growth verticals such as Battery Chemicals and Semiconductors. In Q2 FY26, our revenue grew by 24.1% year-on-year to Rs 306.2 crore, driven by strong performance in Advanced Pharmaceutical Intermediates and stable contributions from Specialty Chemicals. We remain confident of delivering around 25% revenue growth for the full year, backed by a resilient business foundation and clear strategic direction.' Acutaas Chemicals is a speciality chemicals manufacturer serving a wide range of industries, including pharmaceuticals, semiconductors, battery chemicals, personal care, agrochemicals, and fine chemicals. The scrip hit all-time high at Rs 1649.60 in intraday today.Powered by Capital Market - Live

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live

Acutaas Chemicals announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live